Publications 2015

(1) T. Rogez-Florent, N. Azaroual, L. Goossens, J-F Goossens, C Danel

NMR investigation of the complexation and chiral discrimination of pyrazole sulfonamide derivatives with cyclodextrins

Carbohydrate Polymers 115 (2015) 598-604 - Impact factor: 4.33


(2) E. Landagary, S. Yous, C. Vaccher, E. Lipka

Enantioseparation and thermodynamic study of naphthalene derivatives, new melatoninergic agonists, on coated amylose [tris(S)-1-phenylethylcarbamate] stationary phase. Transposition to preparative scale

Biomedical Chromatography (2015) - Impact factor: 1.945

(3) E. Lipka, C. Vaccher

Bioanalytical applications of high performance liquid chromatography with fluorescence detection.

Bioanalysis (2015) - Impact factor: 3.027 

(4) D. Baudelet, C. Furman, A. Ghinet, X. Dezitter, S. Adriouch, F. Capet, T. Rogez-Florent, P. Gautret, B. Rigo, R. Millet, C. Vaccher, E. Lipka

Evaluation and comparison of three different separation techniques for analysis of retroamide enantiomers and their biological evaluation against h-P2X7 receptor

Journal of Chromatography B (2015) - Impact factor: 2.694


(5) A. Foinard, M. Perez, C. Barthélémy, D. Lannoy, F. Flamein, L. Storme, A. Addad, M.-A. Bout, B. Décaudin, P. Odou

In vitro assessment of interaction between amino acids and copper in neonatal parenteral nutrition.

JPEN J Parenteral Enteral Nutr. 2015


(6) M. Perez, B. Decaudin, W. Abou-Chala, B. Nelken, C. Barthélémy, G. Lebuffe, P. Odou

In vitro analysis of the overall particulate contamination exposure during multidrug IV therapy: impact of infusion sets. 

Pediatric Blood & Cancer 2015


(7) A. Foinard, M. Perez, C. Barthélémy, D. Lannoy, F. Flamein, L. Storme, A. Tournoys, B. Décaudin, P. Odou

Assessment of anti-factor Xa activity of heparin in binary parenteral nutrition admixtures for premature neonates.

Annales Pharmaceutiques Françaises 2015


(8) M. Perez, B. Décaudin, A. Foinard, C. Barthélémy, B. Debaene, G. Lebuffe, P. Odou

Compatibility of medications during multi-infusion therapy: a controlled in vitro study on a multilumen infusion device.

Anaesth Crit Care Pain Med. 2015 


(9) S. Genay, B. Décaudin, S. Scoccia, C. Barthélémy, B. Debaene, G. Lebuffe, P. Odou

An in vitro evaluation of infusion methods using a syringe pump to improve noradrenaline administration.

Acta Anaesthesiologica Scandinavica 59 (2015) 197-204


(10) M. Drouet, F. Chai, C. Barthélémy, G. Lebuffe, B. Debaene, B. Décaudin, P. Odou

Influence of vancomycin infusion methods on endothelial cell toxicity

Antimicrobial Agents and Chemotherapy 59 (2015) 930-934


(11) S. Ravez, N. Schifano, A. Barczyk, S. Arsenlis, O. Castillo-Aguilera, B. Baldeyrou, A. Lansiaux, P. Six, J.F. Goossens, P. Depreux, L.Goossens.

Synthesis and antiproliferative activity of 2-amino-4-anilinoquinazoline derivatives. 

Medicinal Chemistry 5 (2015) 67-76 


(12) S. Ravez, O. Castillo-Aguilera, P. Depreux, L. Goossens.

Quinazoline derivatives as anticancer drugs : a patent review (2011-present).

Expert Opinion Therapeutic Patent, (2015), 25. (IF : 3.44)


(13) F. Feutry, N. Simon, S. Genay, D. Lannoy, C. Barthélémy, B. Décaudin, P. Labalette, P. Odou

Stability of 10 mg/mL cefuroxime solution for intracameral injection in new ready-to-use cyclic olefin copolymer (COC) sterile vials

Drug Development and Industrial Pharmacy 2015


(14) P. Six, J.F. Goossens, W. Riquet, V. Brel, E. Fournier, J.P. Annereau, A. Kruczynski, O. Castillo-Aguilera, P. Depreux, C. Bailly, L. Goossens

Hemisynthesis of anisomycin derivatives as antitumor agents.

Medicinal Chemistry 5 (2015) 183-191 (IF :1.37)


(15) Bernard L, Cueff R, Breysse C, Décaudin B, Sautou V; Armed Study Group

Migrability of PVC plasticizers from medical devices into a simulant of infused solutions.

Int J Pharm. 485 (2015) 341-347 


(16) N. Simon N, O. Romano, P. Michel, C. Pinçon, M. Vasseur, N. Lemahieu, C. Barthélémy, M. Hebbar, B. Décaudin, P. Odou

Influence of infusion method on gemcitabine pharmacokinetics: a controlled randomized multicenter trial.

Cancer Chemother Pharmacol. 76 (2015) 865-871 (IF : 2.769)


(17) M. Drouet, F. Chai, C. Barthélémy, G. Lebuffe, B. Debaene, B. Décaudin, P. Odou.

Endothelial cell toxicity of vancomycin infusion combined with other antibiotics.  

 Antimicrob Agents Chemother. 59 (2015) 4901-4906


 (18) M. Anastasi, S. Rudaz, T. Queruau Lamerie, P. Odou, P. Bonnabry, S. Fleury-Souverain.

Efficacy of two cleaning solutions for the decontamination on 10 antineoplastic agents in the biosafety cabinets of a hospital pharmacy. 

Ann Occup Hyg. 2015.


(19) O. Sidikou, N. Simon, G. Sergent, M. Vasseur, M. Pinturaud, C. Richeval, D. Allorge, B. Décaudin, P. Odou.

In vitro assessment of a new extension set intended to reduce occupational exposure to antineoplasic drugs during hepatic chemoembolisation.  

Cardiovasc Intervent Radiol. 2015. 


(20) M. Lecoeur, Y. Guillotin, B. Decaudin, V. Sautou, C. Vaccher, for the ARMED study group

Comparison of high-performance liquid chromatography and supercritical fluid chromatography using evaporative light scattering detection for the determination of plasticizers in medical devices

J. Chromatogr. A 1417 (2015) 104-115 (IF 4,169)


(21) S. Welti, P.Moreau, C. Decock, C. Danel, N. Duhal, A. Favel, R. Courtecuisse

Oxygenated lanostane-type triterpenes profiling in laccate Ganoderma Chemotaxonomy

Mycological Progress 14 (2015) 1-15 (IF 1,913)


(22) Maurer MJ, Jais JP, Ghesquières H, Witzig TE, Hong F, Haioun C, Thompson CA, Thieblemont C, Micallef IN, Porrata LF, Ribrag V, Nowakowski GS, Casanovas O, Bologna S, Morschhauser F, Morrison VA, Peterson BA, Macon WR, Copie-Bergman C, Feldman AL, Syrbu SI, Kurtin PJ, Gascoyne RD, Li H, Allmer C, Kahl BS, Ansell SM, Slager SL, Link BK, Salles G, Habermann TM, Tilly H, Cerhan JR. 

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large b-cell lymphoma. 

Am J Hematol. 2015


(23) Freeman CL, Morschhauser F, Sehn L, Dixon M, Houghton R, Lamy T, Fingerle-Rowson G, Wassner-Fritsch E, Gribben JG, Hallek M, Salles G, Cartron G.

Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion related reactions. 

Blood 2015


(24) Gribben JG, Fowler N, Morschhauser F. 

Mechanisms of action of lenalidomide in B-cell Non Hodgkin Lymphoma. 

J Clin Oncol 2015 1 ; 33 (25) : 2803-11.


(25) Palanca-Wessels MC, Czuczman M, Salles G, Assouline S, Sehn LH, Flinn I, Patel MR, Sangha R, Hagenbeek A, Advani R, Tilly H, Casasnovas O, Press OW, Yalamanchili S, Kahn R, Dere RC, Lu D, Jones S, Jones C, Chu YW, Morschhauser F. 

Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed of refractory B-celle non-Hodgkin lymphoma and chronic lymphocyttic leukaemia : a phase 1 study. 

Lancet Oncology. 2015 ; 16(6) ; 704-15. 


(26) Rossignol J, Terriou L, Robu D, Willekens C, Hivert B, Pascal L, Guieze R, Trappe R, Baillet C, Huglo D, Morschhauser F.  

Radioimmunotherapy ((90) Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab. 

Am J Transplant. 2015 Jul;15(7):1976-81. 


(27) Trappe RU, Choquet S, Dierickx D, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Tarella C, Shpilberg O, Sender M, Salles G, Morschhauser F, Jaccard A, Lamy T, Reinke P, Neuhaus R, Lehmkuhl H, Horst HA, Leithäuser M, Schlattmann P, Anagnostopoulos I, Raphael M, Riess H, Leblond V, Oertel S; German PTLD Study Group and the European PTLD Network.

International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.

Am J Transplant. 2015 ;15(4):1091-100. 


(28) Boyle EM, Morschhauser F.

Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma.

Expert Opin Drug Saf. 2015 ;14(4):601-7.


(29) Pfeifer M, Zheng B, Erdmann T, Koeppen H, McCord R, Grau M, Staiger A, Chai A, Sandmann T, Madle H, Dörken B, Chu YW, Chen AI, Lebovic D, Salles GA, Czuczman MS, Palanca-Wessels MC, Press OW, Advani R, Morschhauser F, Cheson BD, Lenz P, Ott G, Polson AG, Mundt KE, Lenz G.

Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.

Leukemia. 2015 ;29(7):1578-86. 


(30) Lefèvre G, Copin MC, Roumier C, Aubert H, Avenel-Audran M, Grardel N, Poulain S, Staumont-Sallé D, Seneschal J, Salles G, Ghomari K, Terriou L, Leclech C, Morati-Hafsaoui C, Morschhauser F, Lambotte O, Ackerman F, Trauet J, Geffroy S, Dumezy F, Capron M, Roche-Lestienne C, Taieb A, Hatron PY, Dubucquoi S, Hachulla E, Prin L, Labalette M, Launay D, Preudhomme C, Kahn JE; on behalf the French Eosinophil Network.

CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.

Haematologica. 2015 ;100(8):1086-95.


(31) Poulain S, Boyle EM, Tricot S, Demarquette H, Doye E, Roumier C, Duthilleul P, Preudhomme C, Maurage CA, Morschhauser F.

Absence of CXCR4 mutations but high incidence of double mutant in CD79A/B and MYD88 in primary central nervous system lymphoma.

Br J Haematol. 2015 ;170(2):285-7. 


(32) von Tresckow B, Morschhauser F, Ribrag V, Topp MS, Chien C, Seetharam S, Aquino R, Kotoulek S, de Boer CJ, Engert A.

An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma.

Clin Cancer Res. 2015 ;21(8):1843-50.


(33) N. Simon, O. Romano, P. Michel, C. Pinçon, M. Vasseur, N. Lemahieu, C. Barthélémy, M. Hebbar, B. Décaudin, P. Odou

Influence of infusion method on gemcitabine pharmacokinetics: a controlled randomized multicenter trial  

Cancer Chemotherapy and Pharmacology in press


(34) S. Genay, B. Décaudin, S. Lede, F. Feutry, C. Barthélémy, G. Lebuffe, P. Odou. 

In vitro comparison of two changeover methods for vasoactive drug infusion pumps: Quick-change versus Automated relay.

Biomedical Engineering / Biomedizinische Technik (Biomed. Eng.- Biomed. Tech.) 60 (4):377-80. 2015.


(35) N. Simon, M. Vasseur, A. Guillaussier, J-F Legrand, M. Lebecque, C. Barthélémy, B. Décaudin, P. Odou.

Potential impact of the infusion technique on drug delivery.  

Therapeutic Drug Monitoring in press. 


(36) Kambia N, Farce A, Belarbi K, Gressier B, Luyckx M, Chavatte P, Dine T. 

Docking study : PPARs interaction with the selected alternative plasticizers to di(2-ethylhexyl)phthalate.

J Enzyme Inhib Med Chem. 2015 5:1-8. 


(37) Farhat MM, Chanson N, Baillet C, Stichelbout M, Pokeerbux R, Hatron PY, Hachulla E. 

Une pseudo-tumeur pancréatique. 

La Revue de Médecine Interne 2015 36 (11) : 786-7.


(38) Schaefer A, Vermandel M, Baillet C, Dewalle-Vignion AS, Modzelewski R, Vera P, Massoptier L, Parcq C, Gibon D, Fechter T, Nemer U, Gardin I, Nestle U.

Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation. 

Eur J Nucl Med Mol Imaging 2015.  



(39) Dewalle-Vignion AS, Betrouni N, Baillet C, Vermandel M. 

Is STAPLE algorithm confident to assess segmentation methods in PET imaging ? 

Phys Med Biol 2015 19 ; 60 (24):9473-91. 



(40) Jaillard A, Baillet C, Beron A, Tabibzadeh N, Scherpereel A, Frimat M, Perbet R, Gnemmi V, Noël C, Huglo D.

FDG PET/CT allowing detection and follow-up of tumor cell transplantation.

Ann Nucl Med 2015



(41) S. Ravez , S. Arsenlis, A. Barczyk, A. Dupont, R. Frederick , S. Hesse, G. Kirsch, P. Depreux, L. Goossens

Synthesis and biological evaluation of di-aryl urea derivatives as c-Kit inhibitors.

Bioorganic Medicinal Chemistry 23 (2015) 7540-7547.